1型糖尿病规范化管理的难点与展望  

Difficulties and prospects of standardized management of type 1 diabetes

作　　者：顾楠[1] 郭晓蕙[1] Gu Nan;Guo Xiaohui(Endocrinology Department,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院内分泌科,北京100034

出　　处：《中华医学杂志》2022年第16期1148-1152,共5页National Medical Journal of China

基　　金：国家重点研发计划 (2017YFC1309604)。

摘　　要：1型糖尿病需要终生依赖胰岛素治疗,长期维持血糖平稳,减少急慢性并发症的发生,对患者而言是长期存在的挑战。对1型糖尿病患者的管理涉及多学科协作、不同医院的转诊,以及对患者和家庭成员有效的糖尿病教育和管理。相较于美国、英国等国家较成熟的糖尿病管理和教育体系,我国对1型糖尿病患者的规范化管理工作开始的较晚,目前仍存在一些难点和困惑。但随着各级卫生部门对1型糖尿病患者管理模式的探索和努力,1型糖尿病患者的管理必将逐步进入规范化,真正实现对患者的终身管理。Type 1 diabetes patients require lifelong dependence on insulin therapy.It is a long-term challenge for patients to effectively deliver exogenous insulin to maintain glucose levels within the individual′s target range as safely as possible for preventing the development and progression of diabetes complications.The management of type 1 diabetes involves multidisciplinary collaboration,referral from different hospitals,and effective diabetes education and management for patients and family members.Compared with the more mature diseases management system in the United States and the United Kindom,the standardized management of type 1 diabetes patients in China started late.Moreover,there are still some difficulties at present.Whereas,with the exploration and efforts of the hospitals at all levels for the management of type 1 diabetes patients,standardization of type 1 diabetes management will gradually step forward and truly realize the lifelong management for patients.

关 键 词：1型糖尿病 糖尿病教育 疾病管理 

分 类 号：R587.1[医药卫生—内分泌]